India  
 
NewsR.in

Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor

Video Credit: ANI - Duration: 01:46s - Published
Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor

Part 1 of phase-1 Covaxin trial shows encouraging results: Rohtak PGI Doctor

As the world is scrambling to develop a COVID-19 vaccine, Principal Investigator of vaccine trial team at Rohtak PGI Doctor Savita Verma informed that part 1 of phase-1 of Covaxin trial is completed and it shows encouraging results.

"Part 1 of phase-1 of vaccine trial (Covaxin) completed.

50 people across India were administered the vaccine, results encouraging.

6 people were administered vaccine today under part 2 of phase-1," said Verma.


You Might Like


Related videos from verified sources

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak [Video]

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak

The first part of phase-1 of Covaxin human trial completed on Saturday. The trial was conducted at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr Savita Verma, principal..

Credit: HT Digital Content     Duration: 02:37Published
Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak [Video]

Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak

Human trials of a Covid vaccine candidate, developed in India, have begun. Trials of the drug named Covaxin are being conducted at PGIMS, Rohtak. Bharat Biotech and ICMR's National Institute of..

Credit: HT Digital Content     Duration: 02:50Published
Haryana starts clinical trials for coronavirus vaccine 'covaxin' at PGIMS Rohtak [Video]

Haryana starts clinical trials for coronavirus vaccine 'covaxin' at PGIMS Rohtak

Haryana started clinical trials for coronavirus vaccine 'covaxin' at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) in Rohtak. Vice-Chancellor OP Kalra said, "Today, we..

Credit: ANI     Duration: 02:32Published